ELOVL6-IN-5
ELOVL6-IN-5 (compound B) is an inhibitor of the elongase enzyme of long-chain fatty acid family 6 (ELOVL6) . ELOVL6 is a rate-limiting enzyme for the elongation of saturated and monounsaturated long-chain fatty acids and is an effective target for inhibiting diabetes. ELOVL6-IN-5 reduces hepatic fatty acid levels in a mouse model of diet-induced obesity (DIO) . However, ELOVL6 inhibition by ELOVL6-IN-5 did not improve insulin resistance[1].
Product Specifications
CAS Number
1135000-36-0
UNSPSC
12352005
Target
ELOVL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/elovl6-in-5.html
Purity
95.12
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N1C2CCC1CC(S(=O)(C3=NC=CC=C3)=O)C2)NC4=CC=C(C(F)(F)F)C=C4
Molecular Formula
C20H20F3N3O3S
Molecular Weight
439.45
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
Cytochrome C (CYCS/1010), CF405S conjugate, 0.1mg/mL
CD31 / PECAM-1 (JC/70A), CF640R conjugate, 0.1mg/mL
CD11c (Dendritic Cell Marker) (ITGAX/1284), CF594 conjugate, 0.1mg/mL
